Annual Retained Earnings
-$632.51 M
-$235.94 M-59.49%
December 31, 2023
Summary
- As of February 12, 2025, DYN annual retained earnings is -$632.51 million, with the most recent change of -$235.94 million (-59.49%) on December 31, 2023.
- During the last 3 years, DYN annual retained earnings has fallen by -$553.33 million (-698.80%).
- DYN annual retained earnings is now -12842.71% below its all-time high of -$4.89 million, reached on December 31, 2018.
Performance
DYN Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$860.39 M
-$97.13 M-12.73%
September 30, 2024
Summary
- As of February 12, 2025, DYN quarterly retained earnings is -$860.39 million, with the most recent change of -$97.13 million (-12.73%) on September 30, 2024.
- Over the past year, DYN quarterly retained earnings has dropped by -$97.13 million (-12.73%).
- DYN quarterly retained earnings is now -4257.27% below its all-time high of -$19.75 million, reached on December 31, 2019.
Performance
DYN Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
DYN Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -59.5% | -12.7% |
| 3 y3 years | -698.8% | -70.2% |
| 5 y5 years | -10000.0% | -70.2% |
DYN Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -176.8% | at low | -276.6% | at low |
| 5 y | 5-year | -3103.2% | at low | -4257.3% | at low |
| alltime | all time | <-9999.0% | at low | -4257.3% | at low |
Dyne Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$860.39 M(+12.7%) |
| Jun 2024 | - | -$763.26 M(+9.3%) |
| Mar 2024 | - | -$698.16 M(+10.4%) |
| Dec 2023 | -$632.51 M(+59.5%) | -$632.51 M(+11.8%) |
| Sep 2023 | - | -$565.87 M(+11.9%) |
| Jun 2023 | - | -$505.66 M(+14.7%) |
| Mar 2023 | - | -$440.76 M(+11.1%) |
| Dec 2022 | -$396.57 M | -$396.57 M(+10.9%) |
| Sep 2022 | - | -$357.75 M(+13.1%) |
| Jun 2022 | - | -$316.36 M(+19.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -$264.06 M(+15.6%) |
| Dec 2021 | -$228.47 M(+188.5%) | -$228.47 M(+29.3%) |
| Sep 2021 | - | -$176.69 M(+31.8%) |
| Jun 2021 | - | -$134.11 M(+28.8%) |
| Mar 2021 | - | -$104.15 M(+31.5%) |
| Dec 2020 | -$79.18 M(+301.0%) | -$79.18 M(+56.7%) |
| Sep 2020 | - | -$50.53 M(+38.0%) |
| Jun 2020 | - | -$36.61 M(+85.4%) |
| Dec 2019 | -$19.75 M(+304.1%) | -$19.75 M |
| Dec 2018 | -$4.89 M | - |
FAQ
- What is Dyne Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Dyne Therapeutics?
- What is Dyne Therapeutics annual retained earnings year-on-year change?
- What is Dyne Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Dyne Therapeutics?
- What is Dyne Therapeutics quarterly retained earnings year-on-year change?
What is Dyne Therapeutics annual retained earnings?
The current annual retained earnings of DYN is -$632.51 M
What is the all time high annual retained earnings for Dyne Therapeutics?
Dyne Therapeutics all-time high annual retained earnings is -$4.89 M
What is Dyne Therapeutics annual retained earnings year-on-year change?
Over the past year, DYN annual retained earnings has changed by -$235.94 M (-59.49%)
What is Dyne Therapeutics quarterly retained earnings?
The current quarterly retained earnings of DYN is -$860.39 M
What is the all time high quarterly retained earnings for Dyne Therapeutics?
Dyne Therapeutics all-time high quarterly retained earnings is -$19.75 M
What is Dyne Therapeutics quarterly retained earnings year-on-year change?
Over the past year, DYN quarterly retained earnings has changed by -$97.13 M (-12.73%)